• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

mutation carriers with malignant pheochromocytoma respond better to CVD.

作者信息

Fishbein L, Ben-Maimon S, Keefe S, Cengel K, Pryma D A, Loaiza-Bonilla A, Fraker D L, Nathanson K L, Cohen D L

机构信息

Division of EndocrinologyMetabolism and Diabetes and Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado School of Medicine, University of Colorado Cancer Center, Aurora, Colorado, USA

Department of MedicinePerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Endocr Relat Cancer. 2017 Aug;24(8):L51-L55. doi: 10.1530/ERC-17-0086. Epub 2017 May 31.

DOI:10.1530/ERC-17-0086
PMID:28566531
Abstract
摘要

相似文献

1
mutation carriers with malignant pheochromocytoma respond better to CVD.患有恶性嗜铬细胞瘤的突变携带者对心血管疾病（CVD）的反应更好。
Endocr Relat Cancer. 2017 Aug;24(8):L51-L55. doi: 10.1530/ERC-17-0086. Epub 2017 May 31.
2
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.SDHB突变与转移性嗜铬细胞瘤或副神经节瘤患者对替莫唑胺的反应相关。
Int J Cancer. 2014 Dec 1;135(11):2711-20. doi: 10.1002/ijc.28913. Epub 2014 May 5.
3
[Malignant pheochromocytoma].[恶性嗜铬细胞瘤]
Nihon Rinsho. 2006 May 28;Suppl 1:739-43.
4
Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.环磷酰胺、长春新碱和达卡巴嗪联合治疗控制肿瘤进展可提高转移性和不可切除性恶性嗜铬细胞瘤/副神经节瘤患者的生存率。
Horm Cancer. 2017 Apr;8(2):108-118. doi: 10.1007/s12672-017-0284-7. Epub 2017 Jan 20.
5
Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline.含蒽环类药物的联合化疗成功治疗恶性嗜铬细胞瘤。
Ann Oncol. 2003 Sep;14(9):1449-51. doi: 10.1093/annonc/mdg358.
6
Malignant pheochromocytoma associated with germline mutation of the SDHB gene.与SDHB基因种系突变相关的恶性嗜铬细胞瘤。
J Urol. 2004 Oct;172(4 Pt 1):1409-10. doi: 10.1097/01.ju.0000137892.89141.6a.
7
Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia.
Horm Res. 1998;49(6):295-7. doi: 10.1159/000023190.
8
Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paraganglioma.转移性嗜铬细胞瘤和副神经节瘤患者根据胚系突变状态进行全身治疗的结果。
Clin Genitourin Cancer. 2024 Apr;22(2):413-419. doi: 10.1016/j.clgc.2023.12.012. Epub 2023 Dec 25.
9
Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.环磷酰胺、长春新碱和达卡巴嗪治疗恶性副神经节瘤和嗜铬细胞瘤的化疗：系统评价和荟萃分析。
Clin Endocrinol (Oxf). 2014 Nov;81(5):642-51. doi: 10.1111/cen.12542. Epub 2014 Jul 30.
10
Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.环磷酰胺、长春新碱和达卡巴嗪治疗恶性嗜铬细胞瘤/副神经节瘤：18例患者22年随访结果的建议
Cancer. 2008 Oct 15;113(8):2020-8. doi: 10.1002/cncr.23812.

引用本文的文献

1
Late-Onset Bone Metastasis 46 Years After Initial Surgery for Pheochromocytoma: A Case Report.嗜铬细胞瘤初次手术后46年发生的迟发性骨转移：一例报告
IJU Case Rep. 2025 Aug 13;8(5):533-538. doi: 10.1002/iju5.70086. eCollection 2025 Sep.
2
A novel germline (c.314T>A) variant in metastatic paraganglioma: case report and literature review.转移性副神经节瘤中的一种新型种系（c.314T>A）变异：病例报告及文献综述
Front Endocrinol (Lausanne). 2025 Mar 27;16:1577421. doi: 10.3389/fendo.2025.1577421. eCollection 2025.
3
Durable and deep response to CVD chemotherapy in SDHB-mutated metastatic paraganglioma: case report.
SDHB突变型转移性副神经节瘤对CVD化疗的持久且深度反应：病例报告
Front Endocrinol (Lausanne). 2024 Dec 18;15:1483516. doi: 10.3389/fendo.2024.1483516. eCollection 2024.
4
Perspective review: lessons from successful clinical trials and real-world studies of systemic therapy for metastatic pheochromocytomas and paragangliomas.观点综述：转移性嗜铬细胞瘤和副神经节瘤系统治疗的成功临床试验及真实世界研究的经验教训
Ther Adv Med Oncol. 2024 Nov 21;16:17588359241301359. doi: 10.1177/17588359241301359. eCollection 2024.
5
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.SDHB 种系致病性变异患者的嗜铬细胞瘤和副神经节瘤的管理：国际专家共识声明。
Nat Rev Endocrinol. 2024 Mar;20(3):168-184. doi: 10.1038/s41574-023-00926-0. Epub 2023 Dec 14.
6
An Update on Temporal Bone Paragangliomas.关于颞骨副神经节瘤的最新进展。
Curr Treat Options Oncol. 2023 Oct;24(10):1392-1407. doi: 10.1007/s11864-023-01127-7. Epub 2023 Aug 9.
7
Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes.嗜铬细胞瘤和副神经节瘤：胚系遗传学与遗传综合征
Endocr Oncol. 2022 Jun 28;2(1):R65-R77. doi: 10.1530/EO-22-0044. eCollection 2022 Jan.
8
SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis.SDHB 免疫组化在嗜铬细胞瘤和副神经节瘤预后中的作用：回顾性和前瞻性分析。
Front Endocrinol (Lausanne). 2023 Mar 16;14:1121397. doi: 10.3389/fendo.2023.1121397. eCollection 2023.
9
exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas.外显子1缺失：哥伦比亚嗜铬细胞瘤和副神经节瘤患者中一种反复出现的种系突变。
Front Genet. 2023 Jan 4;13:999329. doi: 10.3389/fgene.2022.999329. eCollection 2022.
10
Novel Germline Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia.转移性嗜铬细胞瘤和慢性髓性白血病中新型种系变异，但无红细胞增多症。
Medicina (Kaunas). 2022 Aug 17;58(8):1113. doi: 10.3390/medicina58081113.